$859.00 – $3,799.00
Indications for the drug Imfinzi (Imainzi):
– unresectable locally advanced non-small cell lung cancer in adult patients who have not demonstrated disease progression after platinum-based chemoradiotherapy;
– first line of treatment for advanced small cell lung cancer in combination with etoposide and carboplatin or cisplatin;
– locally advanced or metastatic cancer of the biliary system in combination with chemotherapy.
Active ingredient: durvalumab
Prescription medicine
| Дозировка | 120 Mg, 500 Mg |
|---|
